Introduction: Setting New Standards in Aromatase Inhibitor Therapy
Development of Aromatase Inhibitors and Their Pharmacologic Profile
A Comparison of the Efficacy of Aromatase Inhibitors in Second-Line Treatment of Metastatic Breast Cancer
Applicability of the Intratumor Aromatase Preclinical Model to Predict Clinical Trial Results With Endocrine Therapy
Emerging Role of Aromatase Inhibitors in the Adjuvant Setting
Role of Biologic Markers in Patient Selection and Application to Disease Prevention
Examining Quality of Life Issues in Relation to Endocrine Therapy for Breast Cancer